Advertisement

Topics

In first, FDA approves RNA interference drug from Alnylam

09:00 EDT 10 Aug 2018 | BioPharmaDive

Alnylam's drug, called Onpattro, treats a rare genetic disease known as hATTR amyloidosis, for which few other therapies exist.

Original Article: In first, FDA approves RNA interference drug from Alnylam

NEXT ARTICLE

More From BioPortfolio on "In first, FDA approves RNA interference drug from Alnylam"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...